Project Grant R21NS143271
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$430K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This federal Project Grant award of $430,375.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research by Emory University to investigate neurogenic defects in cellular models of Fragile X Syndrome. The project aims to determine if cyclic AMP signaling is disrupted during early brain development in Fragile X Syndrome and whether targeting the microtubule-associated protein Doublecortin could have therapeutic...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research exploring the role of the extracellular signaling protein Reelin and its potential for therapeutic application in Fragile X Syndrome (FXS). The $187,500 award to the University of South Florida aims to validate a gene therapy approach using an optimized Reelin...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $596,937.00 to investigate the role of the FMRP protein in regulating mitochondrial function and energy metabolism in human neuron development. The research aims to elucidate the mechanisms by which FMRP and its target RACK1 regulate activity-dependent mitochondrial...
Emory University received a $430,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to elucidate the subcellular dynamics of ubiquitination, a key biological process regulating synaptic function and neuronal health, using advanced single-molecule imaging techniques. The research aims to uncover new mechanisms by...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to understand the molecular mechanisms governing lymphatic dysfunction in a mouse model of neurodevelopmental disorder (Fragile X syndrome) and its involvement in social and behavioral impairments. The $836,125.47 award to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University will fund a 5-year research project to: 1)...
The Washington University Office of Sponsored Research Services Division received a $427,625 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research to unravel the role of satellite glial cells in sensory hypersensitivity in Fragile X Syndrome, a leading genetic cause of autism spectrum disorders. Key activities include: Examining how...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $375,822 to The Trustees of the University of Pennsylvania to investigate the mechanisms by which the expansion of a short tandem repeat (STR) sequence in the FMR1 gene causes transcriptional silencing and heterochromatin formation in Fragile X Syndrome. The research aims to leverage CRISPR/Cas9...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $244,154 to Albert Einstein College of Medicine to investigate the regulation of presynaptic gene transcripts during synaptogenesis. The project aims to characterize the dynamics of the essential presynaptic active zone gene syd-2/liprin-alpha mRNA and identify novel candidates of mRNA...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $515,898 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) Division. This 5-year grant aims to investigate the contribution of astrocytes, a type of glial cell, to sleep impairments in Fragile X Syndrome (FXS) and Autism Spectrum Disorders...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $404,340 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Georgia Research Foundation, Inc. The project aims to develop a novel method using split fluorescent protein tags to map the localization of neurotransmitter receptors within neural circuits in the Drosophila model organism. This work will provide crucial new insights into the...